Izotropic Corporation (OTCMKTS:IZOZF) Shares Shorted: Short Interest Up 1,938.3% in September

Izotropic Corporation (OTCMKTS:IZOZF) saw a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 17,142 shares, a growth of 1,938.3% from the September 15th total of 841 shares. Based on an average trading volume of 38,591 shares, the short-interest ratio is presently 0.4 days. Currently, 0.0% of the company’s stock are sold short.

Izotropic Price Performance

IZOZF traded down $0.00 during trading on Friday, hitting $0.12. The stock had a trading volume of 126,600 shares, compared to its average volume of 22,425. The stock has a 50 day simple moving average of $0.16 and a two-hundred day simple moving average of $0.18. Izotropic has a twelve month low of $0.10 and a twelve month high of $0.37.

Izotropic (OTCMKTS:IZOZF) last issued its quarterly earnings data on Monday, September 28th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.02). As a group, analysts predict that Izotropic will post 0.03 earnings per share for the current fiscal year.

About Izotropic

Izotropic Corporation is a Canadian medical technology company focused on developing advanced breast-imaging solutions. The company’s principal product is the IzoView Breast CT Imaging System, a dedicated computed tomography platform designed to produce three-dimensional images of breast tissue.

IzoView is intended to support the detection, visualization and diagnosis of breast abnormalities by providing volumetric imaging rather than conventional two-dimensional views. The system is designed to image the breast without the compression used in traditional mammography, with the goal of improving the patient experience and helping clinicians evaluate complex breast tissue.

Izotropic is focused on the continued development, validation and potential commercialization of its technology for use in breast cancer screening and diagnostic imaging.